Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxacin) Under Fasting Condition in Healthy Adult Pakistani Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

April 23, 2019

Study Completion Date

April 27, 2019

Conditions

Bioequivalence

Interventions

DRUG

Moksi® 400mg Tablet

Single dose of Moxifloxacin 400 mg Tablet was administered after a 10-hour overnight fast.

DRUG

Drug: Avelox® 400Mg Tablet

Single dose of Moxifloxacin 400 mg Tablet was administered after a 10-hour overnight fast.

Trial Locations (1)

Center for Bioequivalence Studies and Clinical Research (CBSCR) ICCBS, University of Karachi, Karachi